1. Home
  2. AWRE vs GDTC Comparison

AWRE vs GDTC Comparison

Compare AWRE & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • GDTC
  • Stock Information
  • Founded
  • AWRE 1986
  • GDTC 2018
  • Country
  • AWRE United States
  • GDTC Singapore
  • Employees
  • AWRE N/A
  • GDTC N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • GDTC Health Care
  • Exchange
  • AWRE Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • AWRE 35.2M
  • GDTC 29.4M
  • IPO Year
  • AWRE 1996
  • GDTC 2023
  • Fundamental
  • Price
  • AWRE $1.70
  • GDTC $2.77
  • Analyst Decision
  • AWRE
  • GDTC Buy
  • Analyst Count
  • AWRE 0
  • GDTC 1
  • Target Price
  • AWRE N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • AWRE 43.2K
  • GDTC 33.6K
  • Earning Date
  • AWRE 03-11-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • AWRE N/A
  • GDTC N/A
  • EPS Growth
  • AWRE N/A
  • GDTC N/A
  • EPS
  • AWRE N/A
  • GDTC N/A
  • Revenue
  • AWRE $16,966,000.00
  • GDTC $330,254.00
  • Revenue This Year
  • AWRE $10.98
  • GDTC $14.71
  • Revenue Next Year
  • AWRE N/A
  • GDTC N/A
  • P/E Ratio
  • AWRE N/A
  • GDTC N/A
  • Revenue Growth
  • AWRE N/A
  • GDTC N/A
  • 52 Week Low
  • AWRE $1.35
  • GDTC $1.20
  • 52 Week High
  • AWRE $2.97
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 56.48
  • GDTC 55.89
  • Support Level
  • AWRE $1.60
  • GDTC $2.35
  • Resistance Level
  • AWRE $1.75
  • GDTC $2.94
  • Average True Range (ATR)
  • AWRE 0.10
  • GDTC 0.24
  • MACD
  • AWRE 0.01
  • GDTC 0.04
  • Stochastic Oscillator
  • AWRE 86.36
  • GDTC 84.63

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: